GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 52 [WO2022135430] | D-2570
Compound class:
Synthetic organic
Comment: Nomelcitinib (WHO proposed list 134; Feb 2026) is the INN for a Janus kinase inhibitor, that is intended for use as a anti-inflammatory/immunosuppressant agent. The chemical structure is claimed in patent WO2022135430A1 (InventisBio) [1]. This may be the INN for their lead orally bioavailable tyrosine kinase 2 (TYK2) JH2 pseudokinase inhibitor D-2570.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
Download 2D Structure ![]() |
|
| Canonical SMILES | Download |
| Isomeric SMILES | Download |
| InChI standard identifier | Download |
| InChI standard key | Download |
Molecular structure representations generated using Open Babel